Get the Stockscreener App
21.88
3.69%
-0.8583
Liquidia Corp stock is traded at $21.88, with a volume of 1.00M.
It is down -3.69% in the last 24 hours and down -20.88% over the past month.
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.
See More
Previous Close:
$22.74
Open:
$22.25
24h Volume:
1.00M
Relative Volume:
0.37
Market Cap:
$1.89B
Revenue:
$17.49M
Net Income/Loss:
$-78.50M
P/E Ratio:
-18.23
EPS:
-1.2
Net Cash Flow:
$-52.85M
1W Performance:
-0.18%
1M Performance:
-20.88%
6M Performance:
+50.93%
1Y Performance:
+114.29%
1-Day Range:
$21.86
$22.84
1-Week Range:
$21.14
$24.61
52-Week Range:
$9.71
$29.94
Liquidia Corp Stock (LQDA) Company Profile
Name
Liquidia Corp
Sector
Industry
Phone
919.328.4400
Address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
21.91 | 1.96B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.27 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
608.44 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.44 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
779.03 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
345.21 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Resumed | Jefferies | Buy |
| May-19-25 | Downgrade | Oppenheimer | Perform → Underperform |
| Dec-20-24 | Initiated | Wells Fargo | Overweight |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-19-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Aug-16-24 | Initiated | Raymond James | Outperform |
| Jun-25-24 | Initiated | Oppenheimer | Perform |
| Jan-05-24 | Reiterated | Needham | Buy |
| Sep-19-22 | Resumed | Wedbush | Underperform |
| Sep-01-22 | Downgrade | Wedbush | Neutral → Underperform |
| Jul-22-22 | Initiated | Ladenburg Thalmann | Buy |
| May-31-22 | Initiated | BTIG Research | Buy |
| May-26-22 | Initiated | BofA Securities | Buy |
| Dec-04-20 | Initiated | H.C. Wainwright | Buy |
| Nov-20-20 | Downgrade | Wedbush | Outperform → Neutral |
| Nov-08-18 | Resumed | Jefferies | Buy |
| Sep-05-18 | Initiated | Wedbush | Outperform |
| Aug-20-18 | Initiated | Jefferies | Buy |
| Aug-20-18 | Initiated | Needham | Buy |
View All
Liquidia Corp Stock (LQDA) Latest News
Is Liquidia Corporation (LT4) stock prepared for digital transitionQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
3 Growth Companies With High Insider Ownership Seeing Up To 63% Revenue Growth - simplywall.st
What’s the recovery path for long term holders of Liquidia CorporationWeekly Market Report & AI Powered Buy and Sell Recommendations - newser.com
Breaking PH-ILD Research: Liquidia's LIQ861 16-Week Trial Data to be Revealed at Major CHEST Conference - Stock Titan
Multi asset correlation models including Liquidia CorporationJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
What machine learning models say about Liquidia CorporationWeekly Trade Recap & Risk Controlled Swing Trade Alerts - newser.com
Can Liquidia Corporation (LT4) stock ride next bull market cycleJuly 2025 Outlook & Low Risk High Win Rate Picks - newser.com
Is Liquidia Corporation (LT4) stock a top dividend aristocrat candidate2025 Market Outlook & Low Drawdown Momentum Trade Ideas - newser.com
Liquidia Corporation (LQDA) Presents Strategic Overview at Well Fargo’s Annual Healthcare Conference 2025 - Yahoo Finance
Is it a Wise Move to Buy Liquidia Corp. (LQDA) Shares? - Yahoo Finance
Insider Selling: Liquidia Technologies (NASDAQ:LQDA) Director Sells 45,524 Shares of Stock - MarketBeat
Exit strategy if you’re trapped in Liquidia CorporationMarket Sentiment Report & Reliable Price Action Trade Plans - newser.com
Should you hold or exit Liquidia Corporation nowWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
Combining machine learning predictions for Liquidia Corporation2025 Top Gainers & High Conviction Buy Zone Alerts - newser.com
How to monitor Liquidia Corporation with trend dashboards2025 EndofYear Setup & High Accuracy Trade Alerts - newser.com
Predicting Liquidia Corporation trend using moving averagesJuly 2025 Opening Moves & Free Weekly Watchlist of Top Performers - newser.com
Historical volatility pattern of Liquidia Corporation visualizedTrade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
Tools to monitor Liquidia Corporation recovery probabilityQuarterly Portfolio Report & Expert Approved Momentum Trade Ideas - newser.com
Sentiment Watch: Can WideOpenWest Inc. sustain earnings growthAnalyst Upgrade & Free Technical Confirmation Trade Alerts - خودرو بانک
Liquidia Corporation (LQDA): A Bull Case Theory - Yahoo Finance
Risk Hedge: Does Liquidia Corporation have strong EBITDA marginsVolume Spike & Daily Chart Pattern Signals - khodrobank.com
Bluefin Capital Management LLC Invests $250,000 in Liquidia Technologies, Inc. $LQDA - MarketBeat
Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium - The Manila Times
Liquidia Corporation to Present New Data on LIQ861 at Pulmonary Hypertension Professional Association Symposium - Quiver Quantitative
Breaking PH-ILD Treatment Data: Liquidia's YUTREPIA Shows New Safety Results in ASCENT Trial at PHPN - Stock Titan
Boothbay Fund Management LLC Boosts Holdings in Liquidia Technologies, Inc. $LQDA - MarketBeat
Jefferies Highlights Yutrepia’s Market Edge in Supporting a Buy on Liquidia (LQDA) - MSN
Liquidia Corporation Breakout Confirmed by Volume MetricsJuly 2025 Retail & Daily Volume Surge Signals - beatles.ru
Liquidia Technologies Target of Unusually Large Options Trading (NASDAQ:LQDA) - MarketBeat
Vestal Point Capital LP Cuts Stake in Liquidia Technologies, Inc. $LQDA - MarketBeat
Full technical analysis of Liquidia Corporation stock2025 Price Targets & Low Risk Entry Point Tips - Newser
Heatmap analysis for Liquidia Corporation and competitorsPortfolio Profit Report & Real-Time Buy Zone Alerts - Newser
Is Liquidia Corporation attractive at current valuationJuly 2025 Setups & Advanced Technical Signal Analysis - خودرو بانک
Does Liquidia Corporation have a competitive edge2025 Market Outlook & Accurate Buy Signal Notifications - خودرو بانک
Liquidia Corp director Singh sells $220k in shares By Investing.com - Investing.com Canada
Why United Therapeutics Catapulted 33%, Pulling Insmed, Liquidia With It - MSN
Liquidia Corp director Singh sells $220k in shares - Investing.com India
What the charts say about Liquidia Corporation todayJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
Real time social sentiment graph for Liquidia CorporationMarket Risk Summary & Fast Gain Swing Alerts - Newser
Trend analysis for Liquidia Corporation this week2025 Analyst Calls & Consistent Growth Equity Picks - Newser
Will Liquidia Corporation stock recover after recent drop2025 Market WrapUp & Fast Momentum Stock Entry Tips - Newser
Using economic indicators to assess Liquidia Corporation potentialPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - Newser
Intraday pattern recognizer results for Liquidia CorporationWeekly Profit Recap & Fast Moving Stock Trade Plans - Newser
Using data filters to optimize entry into Liquidia Corporation2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
Strategies to average down on Liquidia CorporationJuly 2025 Weekly Recap & Weekly High Potential Alerts - Newser
Will Liquidia Corporation benefit from macro trendsJuly 2025 Fed Impact & Community Consensus Picks - Newser
Liquidia at Wells Fargo Conference: Strategic Insights on Eutrebia Launch - Investing.com
Liquidia Corp Stock (LQDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):